Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Bepranemab for Patients with Early Alzheimer’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    Belgium France Germany Italy The Netherlands Poland +1
  • Study on the Effects of Semaglutide in Patients with Early Alzheimer’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +15
  • Study on the Effectiveness and Safety of KarXT for Treating Psychosis in Patients with Alzheimer’s Disease

    Not recruiting

    3 1
    Investigated Diseases:
    Belgium Greece Hungary Poland
  • Study on the Effectiveness and Safety of GSK4527226 in Patients with Early Alzheimer’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    Finland France Germany Italy The Netherlands Norway +2
  • Study on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer’s Disease

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Denmark France Germany Italy The Netherlands +2
  • Study on the Effects of GV1001 for Patients with Mild to Moderate Alzheimer’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Finland France Italy The Netherlands Poland Portugal +1
  • Study of ACP-204 for Treating Psychosis in Adults with Alzheimer’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia France Italy Spain
  • Study of BAN2401 (lecanemab) in people with early stage Alzheimer’s disease to evaluate its effectiveness in preventing disease progression

    Not recruiting

    3 1 1 1
    Spain
  • Study on Masupirdine for Treating Agitation in Alzheimer’s Dementia Patients

    Not recruiting

    3 1 1
    Investigated Drugs:
    Croatia Poland
  • Study of Lecanemab (BAN2401) Treatment in People with Early Alzheimer’s Disease: Testing Safety and Effectiveness Over 18 Months

    Not recruiting

    3 1 1
    Investigated Drugs:
    France Germany Italy Spain Sweden